Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcel Kool

Showing results (241-250 of 318) with videos related to

Pageof 32
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2021
Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional TrialsSanthosh A Upadhyaya, Giles W Robinson, Arzu Onar-Thomas, et al.
Cancer Cell|January 23, 2026
IGSF11-VISTA is a critical and targetable immune checkpoint axis in diffuse midline gliomaRaphaël Collot, Cristian Ruiz-Moreno, Celina Honhoff, et al.
Acta Neuropathologica|November 20, 2020
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosisAbigail K Suwala, Damian Stichel, Daniel Schrimpf, et al.
Acta Neuropathologica|May 28, 2021
Targeting fibroblast growth factor receptors to combat aggressive ependymomaDaniela Lötsch, Dominik Kirchhofer, Bernhard Englinger, et al.
Nature Cancer|January 6, 2026
De novo H3.3K27M-altered diffuse midline glioma in human brainstem organoids to dissect GD2 CAR T cell functionNils Bessler, Amber K L Wezenaar, Hendrikus C R Ariese, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew D J Pearson, Sara Federico, Susanne A Gatz, et al.
British Journal of Cancer|July 9, 2026
Paediatric therapeutic development workshop on medulloblastomaClaudia Montiel Equihua, Joseph S Baxter, Jan J Molenaar, et al.
Cell Stem Cell|June 18, 2019
Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma TumorigenesisMiller Huang, Jignesh Tailor, Qiqi Zhen, et al.
Acta Neuropathologica|November 19, 2016
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variantsKristian W Pajtler, Stephen C Mack, Vijay Ramaswamy, et al.
Cancer Cell|July 15, 2020
Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric EpendymomaJohannes Gojo, Bernhard Englinger, Li Jiang, et al.
Pageof 32

Showing results (241-250 of 318) with videos related to

Sort By:
Pageof 32
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2021
Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional TrialsSanthosh A Upadhyaya, Giles W Robinson, Arzu Onar-Thomas, et al.
Cancer Cell|January 23, 2026
IGSF11-VISTA is a critical and targetable immune checkpoint axis in diffuse midline gliomaRaphaël Collot, Cristian Ruiz-Moreno, Celina Honhoff, et al.
Acta Neuropathologica|November 20, 2020
Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosisAbigail K Suwala, Damian Stichel, Daniel Schrimpf, et al.
Acta Neuropathologica|May 28, 2021
Targeting fibroblast growth factor receptors to combat aggressive ependymomaDaniela Lötsch, Dominik Kirchhofer, Bernhard Englinger, et al.
Nature Cancer|January 6, 2026
De novo H3.3K27M-altered diffuse midline glioma in human brainstem organoids to dissect GD2 CAR T cell functionNils Bessler, Amber K L Wezenaar, Hendrikus C R Ariese, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2023
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew D J Pearson, Sara Federico, Susanne A Gatz, et al.
British Journal of Cancer|July 9, 2026
Paediatric therapeutic development workshop on medulloblastomaClaudia Montiel Equihua, Joseph S Baxter, Jan J Molenaar, et al.
Cell Stem Cell|June 18, 2019
Engineering Genetic Predisposition in Human Neuroepithelial Stem Cells Recapitulates Medulloblastoma TumorigenesisMiller Huang, Jignesh Tailor, Qiqi Zhen, et al.
Acta Neuropathologica|November 19, 2016
The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variantsKristian W Pajtler, Stephen C Mack, Vijay Ramaswamy, et al.
Cancer Cell|July 15, 2020
Single-Cell RNA-Seq Reveals Cellular Hierarchies and Impaired Developmental Trajectories in Pediatric EpendymomaJohannes Gojo, Bernhard Englinger, Li Jiang, et al.
Pageof 32